Inhaled nitric oxide for newborns with diaphragmatic hernia
Treatments studied
Part of Genetic & congenital, Heart & circulation, Lungs & breathing clinical trials.
This trial tests whether giving a gas called inhaled nitric oxide helps newborns with a congenital diaphragmatic hernia breathe better and improve lung blood pressure. It's a type of treatment often used to help with lung problems in babies.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your baby has been diagnosed with a Bochdalek-type diaphragmatic hernia (a specific opening in the diaphragm).
- Your baby was born at 34 weeks of pregnancy or later, and is no older than 14 days (2 weeks).
- Your baby has severe breathing problems and high blood pressure in the lungs (pulmonary hypertension).
- Your baby does not have other serious heart defects that need surgery right after birth.
- Your baby has not already received treatments like inhaled nitric oxide for lung blood pressure.
- Your baby is not currently on ECMO (a machine that takes over heart and lung function).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether inhaled nitric oxide gas can help full-term newborns who have severe breathing problems and high blood pressure in their lungs. It aims to improve oxygen levels and reduce the need for more intensive support.
This trial studies whether stopping inhaled nitric oxide (a breathing medicine) can be safely used in newborns with congenital diaphragmatic hernia (CDH). It may help the team decide the best way to use this medicine during early newborn care.
This trial tests whether giving melatonin to full-term newborns with high blood pressure in their lungs (pulmonary hypertension) can help improve their breathing and oxygen levels. It may offer a new treatment option for babies with this condition.
This trial studies whether sildenafil (a medicine that helps relax blood vessels) can improve outcomes in babies born with a congenital diaphragmatic hernia (CDH) after they’ve had surgery. Babies are selected based on an ultrasound/echo of heart function after repair.
This study compares two types of ventilator support for newborns with congenital diaphragmatic hernia. The goal is to see which breathing approach works better and is safer when started very early after birth.
This study provides access to an experimental treatment called inhaled nitric oxide (delivered by the INOpulse device) for people with pulmonary hypertension caused by lung scarring. It aims to see if this treatment can help improve their condition.
Hear when a new Congenital Diaphragmatic Hernia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.